Jane Street Group, LLC Ligand Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 14,452 shares of LGND stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,452

Previous 22,242 35.02%

Holding current value

$1.61 Million

Previous $1.87 Million 22.79%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$82.7 - $110.11 $644,233 - $857,756	-7,790 Reduced 35.02%	14,452 $1.45 Million
Q2 2024 Aug 14, 2024	BUY	$68.53 - $87.91 $222,379 - $285,267	3,245 Added 17.08%	22,242 $1.87 Million
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $1.06 Million - $1.38 Million	15,463 Added 437.55%	18,997 $1.39 Million
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $638,610 - $935,692	-12,883 Reduced 78.47%	3,534 $252,000
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $659,173 - $813,831	11,199 Added 214.62%	16,417 $983,000
Q2 2023 Aug 14, 2023	SELL	$69.53 - $79.33 $104,920 - $119,708	-1,509 Reduced 22.43%	5,218 $376,000
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $441,762 - $518,517	6,727 New	6,727 $494,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $136 - $1.47 Million	13,665 New	13,665 $1.18 Million
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $136 - $1.47 Million	13,665 New	13,665 $1.18 Million
Q4 2021 Feb 15, 2022	BUY	$127.69 - $165.85 $946,693 - $1.23 Million	7,414 Added 169.19%	11,796 $1.82 Million
Q3 2021 Nov 16, 2021	BUY	$102.33 - $144.73 $167,923 - $237,501	1,641 Added 59.87%	4,382 $611,000
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $3.59 Million - $4.94 Million	-31,771 Reduced 92.06%	2,741 $360,000
Q1 2021 May 18, 2021	BUY	$99.52 - $215.83 $2.52 Million - $5.45 Million	25,274 Added 273.59%	34,512 $5.26 Million
Q4 2020 Feb 17, 2021	SELL	$80.55 - $106.05 $2 Million - $2.63 Million	-24,777 Reduced 72.84%	9,238 $919,000
Q3 2020 Nov 17, 2020	BUY	$89.56 - $126.72 $1.47 Million - $2.08 Million	16,433 Added 93.46%	34,015 $3.24 Million
Q2 2020 Aug 17, 2020	SELL	$68.28 - $123.65 $394,248 - $713,955	-5,774 Reduced 24.72%	17,582 $1.97 Million
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $1.81 Million - $2.12 Million	18,673 Added 398.74%	23,356 $2.44 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $288,420 - $401,815	-3,344 Reduced 41.66%	4,683 $466,000
Q2 2019 Aug 15, 2019	BUY	$107.38 - $129.34 $554,617 - $668,041	5,165 Added 180.47%	8,027 $916,000
Q1 2019 May 16, 2019	SELL	$105.93 - $142.47 $1.64 Million - $2.2 Million	-15,448 Reduced 84.37%	2,862 $360,000
Q4 2018 Feb 15, 2019	BUY	$128.36 - $272.13 $1.45 Million - $3.08 Million	11,300 Added 161.2%	18,310 $2.48 Million
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $1.11 Million - $1.44 Million	5,233 Added 294.49%	7,010 $1.92 Million
Q2 2018 Aug 15, 2018	BUY	$150.77 - $207.98 $17,790 - $24,541	118 Added 7.11%	1,777 $368,000
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $229,987 - $302,966	1,659 New	1,659 $274,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Ligand Pharmaceuticals Inc Transaction History